Franklin Resources’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.15M Buy
176,949
+3,990
+2% +$71K ﹤0.01% 1540
2025
Q1
$3.08M Buy
172,959
+16,895
+11% +$301K ﹤0.01% 1533
2024
Q4
$4.65M Sell
156,064
-24,789
-14% -$739K ﹤0.01% 1374
2024
Q3
$2.9M Buy
180,853
+124,793
+223% +$2M ﹤0.01% 1590
2024
Q2
$960K Sell
56,060
-455
-0.8% -$7.79K ﹤0.01% 1938
2024
Q1
$883K Buy
56,515
+2,220
+4% +$34.7K ﹤0.01% 2001
2023
Q4
$811K Buy
+54,295
New +$811K ﹤0.01% 1723
2023
Q3
Sell
-6,902
Closed -$286K 2737
2023
Q2
$286K Buy
6,902
+1,083
+19% +$44.9K ﹤0.01% 2218
2023
Q1
$350K Sell
5,819
-1,390
-19% -$83.6K ﹤0.01% 1810
2022
Q4
$529K Buy
7,209
+909
+14% +$66.7K ﹤0.01% 1681
2022
Q3
$478K Buy
6,300
+1,135
+22% +$86.1K ﹤0.01% 1692
2022
Q2
$360K Buy
5,165
+312
+6% +$21.7K ﹤0.01% 1812
2022
Q1
$402K Buy
4,853
+851
+21% +$70.5K ﹤0.01% 1908
2021
Q4
$301K Sell
4,002
-551
-12% -$41.4K ﹤0.01% 2077
2021
Q3
$528K Sell
4,553
-718
-14% -$83.3K ﹤0.01% 1860
2021
Q2
$1.17M Sell
5,271
-3,842
-42% -$853K ﹤0.01% 1450
2021
Q1
$1.21M Sell
9,113
-94,496
-91% -$12.5M ﹤0.01% 1437
2020
Q4
$17.9M Buy
103,609
+101,504
+4,822% +$17.6M 0.01% 831
2020
Q3
$234K Buy
+2,105
New +$234K ﹤0.01% 1619